8/11/2022 - Monkeypox vaccines
This webinar explored the Australian experience of introducing a new monkeypox vaccine within a global landscape of rapidly emerging evidence and vaccine supply constraints.
8/11/2022: Monkeypox vaccines
01/09/2022: Emerging vaccine preventable diseases and vaccination for travel
12/05/2022: Preventing shingles (herpes zoster) and its complications using zoster vaccines - and a quick update on COVID-19 vaccines
05/04/2022: Managing seasonal respiratory viruses: Flu and SARS-CoV-2 Winter 2022
03/03/2022: Living with COVID-19: Getting back to immunisation business as usual
8/12/2021: COVID-19 in children and adolescents: vaccines, transmission at school and disease outcomes
13/10/2021: Weighing up the benefits and risks of COVID-19 vaccination: a focus on safety - REGISTER NOW
26/08/21 - What's next for Australia's COVID-19 vaccine program?
24/06/2021 - Supporting COVID-19 vaccine access in the Indo-Pacific
30/04/2021: Australia's COVID-19 vaccine program reset: navigating safety, acceptance and uptake
31/03/21: COVID-19 and 2021 influenza vaccines – the how, what, why and when
17/3/2021: COVID-19 vaccine safety in focus
19/2/2021: Out of the starting blocks: COVID-19 vaccination program in Australia - Part 2
12/02/2021 - Out of the starting blocks: COVID-19 vaccination program in Australia - Part 1
23/11/2020 - SARS-CoV-2 vaccine development: is a finish line in sight?
22/09/2020: Learning together – Transmission of SARS-CoV-2 in NSW educational settings
16/6/2020 - National Immunisation Program changes: what you need to know
17/03/2020 - 2020 influenza program update
18/2/2020 - Measles a local, regional and global perspective
10/12/19 - Working together to improve Aboriginal and Torres Strait Islander immunisation
22/10/19 - Addressing parents' immunisation communication and information needs and SKAI eLearning module & provider website launch
23/7/19 - HPV vaccination impact: successes and opportunities
4/6/19- Deadly diseases: a history and the current battle against measles
1/5/19 - Protecting our most vulnerable children from influenza: we can do better
20/3/19 - All you need to know about Flu in 2019 plus great new tool to support vaccination in pregnancy
18/2/2019 - Conversations with vaccine-hesitant parents: how the new SKAI website can help
21/11/18 - Australian Immunisation Register & Handbook Update
3/10/18 - Immunisation through an equity lens: New Zealand and global
19/09/18 Vaccine safety and adverse events following immunisation: a practical approach
11/07/18 - National Immunisation Program schedule changes - Your questions answered
31/05/18 Maternal vaccination: The knowns and unknowns
23/4/18 - Active surveillance for immunisation programs
12/03/18 - Influenza prevention and control: We can do better
22/11/17 - Tailoring Immunization Programmes (TIP)
27/09/17 - Addressing vaccine hesitancy and refusal
23/08/17 Varicella Zoster Virus Vaccines
26/07/17 - Tuberculosis & the Bacille Calmette-Guérin (BCG) vaccine
24/05/17 Maternal Immunisation against Pertussis
22/03/17 - A One Health Approach to the Problem of Q Fever
22/2/17 - Pneumococcal vaccines for elderly adults
UPCOMING - NCIRS Seminar Series - Tuesday 4 June - Deadly diseases: a history and the current battle against measles
Australia saw its first case of monkeypox in May 2022, followed by declaration of monkeypox as a Communicable Disease Incident of National Significance. Vaccination continues to play an important role in the ongoing public health response, but has not been without its challenges. This webinar explored the Australian experience of introducing a new vaccine against an emerging disease within a global landscape of rapidly emerging evidence and vaccine supply constraints.
The webinar covers:
background on monkeypox virus
epidemiology internationally and in Australia, with a closer look at cluster events in Victoria
vaccines available, who should get them and where they can get them
considerations for affected communities in the vaccine program rollout
safety of monkeypox vaccines, including safety of intradermal administration.
Presentation recordings and speakers:
Monkeypox disease and vaccines — Professor Kristine Macartney
Closed captions are available for this video
Professor Kristine Macartney
Director, NCIRS
Kristine Macartney is a paediatrician, infectious disease specialist and vaccinologist. She worked in the USA at the Children's Hospital of Philadelphia and was a founding member of the US Vaccine Education Center.
Kristine's particular interests include translation of evidence into policy and practice, vaccine safety and vaccine preventable diseases research, particularly in viral diseases, including COVID-19, rotavirus, varicella zoster virus, HPV and influenza. She is the senior editor of the Australian Immunisation Handbook, has authored >200 peer-reviewed publications and is a member of key peak advisory committees in Australia, including the Australian Technical Advisory Group on Immunisation (ATAGI).
She is an expert consultant to the World Health Organization (WHO), a member of the WHO Global Advisory Committee on Vaccine Safety (GACVS), a member of WHO-SAGE subcommittees and is the founding chair of the Australian Regional Immunisation Alliance (ARIA).
Kristine has a clinical appointment at The Children's Hospital at Westmead as a Staff Specialist in Infectious Diseases and Microbiology and a conjoint academic appointment as Professor in the Discipline of Child and Adolescent Health, University of Sydney.
Monkeypox: Victorian public health response — Associate Professor Deborah Friedman
Associate Professor Deborah Friedman
Deputy Chief Health officer, Victoria
Deborah Friedman has extensive clinical and academic expertise in infectious diseases. She is a medical doctor in infectious diseases with over 20 years of experience.
She has expertise and a keen interest in infection prevention and control, antimicrobial resistance and Buruli ulcer. She has supported the Victorian Department of Health's COVID-19 pandemic response since July 2020.
She is a Fellow of the Royal Australasian College of Physicians, a national examiner for the college and conjoint Associate Professor and senior lecturer at Deakin University's School of Medicine, Geelong.
Smallpox vaccines against monkeypox: Safety cosiderations — Associate Professor Nicholas Wood
Associate Professor Nicholas Wood MBBS, MPH, FRACP, PhD
Associate Director, Clinical Research and Services, NCIRS
Senior Staff Specialist
Nicholas Wood is a staff specialist general paediatrician and Associate Professor in the Discipline of Child and Adolescent Health at the University of Sydney.
Nick holds an NHMRC Career Development Fellowship. He leads the NSW Immunisation Specialist Service and coordinates the Immunisation Adverse Events Clinic at the Children's Hospital at Westmead.He is a senior investigator on the Primary Health Network Immunisation Support Program.
Nick is interested in maternal and neonatal immunisation, as well as research into vaccine safety, including genetics and long-term outcomes of adverse events following immunisation.
TraX Study: Measuring monkeypox vaccine uptake and real-wold effectiveness — Professor Andrew Grulich
Professor Andrew Grulich
Program Head, HIV Epidemiology and Prevention Program, The Kirby Institute
Professor Andrew Grulich is an internationally renowned authority in the transmission and prevention of HIV and sexually transmissible infections, and in the epidemiological relationship between immune deficiency, infection and cancer.
He is a medical epidemiologist and a public health physician (FAFPHM, 1995), and in 2015 was elected as a Fellow of the Australian Academy of Health and Medical Sciences. He has worked in HIV research for more than 30 years.
His current research focusses mainly on two areas: the transmission and prevention of HIV and sexually transmitted infections in homosexual men, with a focus on biomedical and behavioural prevention, and the intersection between infection, altered immune function and cancer, particularly as it relates to human papillomavirus-related cancer and focusing on anal cancer.
Through his membership of state and federal ministerial advisory committees, he has been centrally involved in the policy response to HIV prevention in Australia.
Remarks on Australia's monkeypox response — Professor Michael Kidd AM
Professor Michael Kidd AM
Deputy Chief Medical Officer — Australian Government Department of Health and Aged Care
Professor Michael Kidd AM has been a general practitioner for 35 years, working in urban and rural areas across Australia, and is a past president of the Royal Australian College of General Practitioners.
He is a world-leading authority on primary healthcare, having worked in senior leadership positions in Australia and around the world, including the World Health Organization and the World Organization of Family Doctors. He has vast experience in national and global health systems.
Monkeypox vaccines — Q&A panel